Your browser doesn't support javascript.
loading
Impacts of Early Guideline-Directed 21-Gene Recurrence Score Testing on Adjuvant Therapy Decision Making.
Dzimitrowicz, Hannah; Mougalian, Sarah; Storms, Sherri; Hurd, Sandra; Chagpar, Anees B; Killelea, Brigid K; Horowitz, Nina R; Lannin, Donald R; Harigopal, Malini; Hofstatter, Erin; DiGiovanna, Michael P; Adelson, Kerin B; Silber, Andrea; Abu-Khalaf, Maysa; Chung, Gina; Zaheer, Wajih; Abdelghany, Osama; Hatzis, Christos; Pusztai, Lajos; Sanft, Tara B.
Afiliación
  • Dzimitrowicz H; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Mougalian S; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Storms S; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Hurd S; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Chagpar AB; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Killelea BK; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Horowitz NR; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Lannin DR; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Harigopal M; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Hofstatter E; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • DiGiovanna MP; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Adelson KB; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Silber A; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Abu-Khalaf M; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Chung G; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Zaheer W; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Abdelghany O; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Hatzis C; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Pusztai L; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
  • Sanft TB; Yale University School of Medicine; Yale New Haven Hospital-Smilow Cancer Hospital, New Haven, CT.
J Oncol Pract ; 13(12): e1012-e1020, 2017 12.
Article en En | MEDLINE | ID: mdl-29048991
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pruebas Genéticas / Quimioterapia Adyuvante / Recurrencia Local de Neoplasia Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Oncol Pract Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pruebas Genéticas / Quimioterapia Adyuvante / Recurrencia Local de Neoplasia Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Oncol Pract Año: 2017 Tipo del documento: Article